Cancer premiums and latency effects: A risk tradeoff approach for valuing reductions in fatal cancer risks (Q928723): Difference between revisions

@@ Property / MaRDI profile type @@
+MaRDI publication profile
@@ Property / MaRDI profile type: MaRDI publication profile / rank @@
+Normal rank
@@ Property / full work available at URL @@
+https://doi.org/10.1007/s11166-008-9032-2
+Normal rank
@@ Property / OpenAlex ID @@
+W2008346906
@@ Property / OpenAlex ID: W2008346906 / rank @@
+Normal rank
@@ Property / cites work @@
+Willingness to pay for mortality risk reductions: does latency matter?
+Normal rank
@@ Property / cites work @@
+Effects of disease type and latency on the value of mortality risk
+Normal rank
@@ Property / cites work @@
+Age, health and the willingness to pay for mortality risk reductions: A contingent valuation survey of Ontario residents
+Normal rank
@@ Property / cites work @@
+A Reference Lottery Metric for Valuing Health
@@ Property / cites work: A Reference Lottery Metric for Valuing Health / rank @@
+Normal rank
@@ Property / cites work @@
+A choice experiment approach to the valuation of mortality
+Normal rank
@@ Property / cites work @@
+The value of a statistical life: A critical review of market estimates throughout the world
+Normal rank